FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj. EBITDA of $32.5M (-3% decline) FY 2026 Revenue Growth of 0-4% FY 2026 Adjusted EBITDA Margin of 30-32% FY 2026 Adjusted Diluted EPS of $0.44-$0.48 RADNOR, Pa., Feb. 26, 2026 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its fourth quarter and full fiscal year 2025 financial results. Fourth Quarter Highlights:Appointment of Jon Resnick as Chief Executive Officer and Member of the Board of Directors, effective January 1st, 2026. Revenue was $103.6 million, compared to $100.4 million in the fourth quarter of 2024, representing growth of 3%.Software revenue was $46.4 million, compared to $42.3 million in the fourth quarter of 2024,...

Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M Continued value driver execution drove full year Adjusted EBITDA of $331.7M Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34 Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026 CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) — Perimeter Solutions, Inc. (NYSE: PRM) (“Perimeter,” “Perimeter Solutions,” or the “Company”), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 31, 2025. Full Year 2025 ResultsNet sales increased 16% to $652.9 million, as compared to $561.0 million in the prior year.Fire Safety net sales...

Solid Execution and Momentum Entering 2026Annual sales of $3.5 billion, in line with guidance Operating income of $516 million, including insurance settlement gain of $28 million EBITDA(1) of $661 million, or 18.9% margin(1), including 0.8% increase from insurance settlement Strong operating cash flow of $557 million 2023-2025 financial objectives met or exceeded and guidance set for 2026-2028 Investment in a U.S. greenfield steel lattice facility to capitalize on the accelerating infrastructure spending trendMONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced financial results for its fourth quarter and year ended December 31, 2025. “We concluded the year with sales in line with our guidance, robust volume momentum in utility products, and EBITDA margin...

PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) —  Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025Reported revenues were $434.9 million, representing a decrease of 1.7% on a reported basis and 2.5% on an organic basis compared to the fourth quarter of 2024.GAAP earnings per diluted share were $(0.02), compared to $0.25 in the fourth quarter of 2024.Adjusted earnings per diluted share were $0.83, compared to $0.97 in the fourth quarter of 2024.Full-Year 2025Reported revenues were $1,635.2 million, representing an increase of 1.5% on a reported basis and a decrease of 0.7% on an organic basis compared to full-year 2024.GAAP earnings per diluted share were $(6.74), compared to $(0.09) in 2024.Adjusted...

Revenue and Adjusted EBITDA results delivered in line with stated full-year targetsFull‑year cost savings exceeded previously communicated targets Highlights:Revenues of $660.5 million for the fourth quarter and $2,723.4 million for the full year Fourth-quarter book-to-bill ratio of 1.14x, resulting in 1.02x book-to-bill for the trailing 12 months GAAP net loss of $(32.5) million, or $(0.35) per diluted share for the fourth quarter; $(986.2) million, or $(10.81) per diluted share for the full year Adjusted EBITDA of $54.0 million for the fourth quarter and $189.9 million for the full year Adjusted net income of $9.2 million, or $0.09 per diluted share for the fourth quarter; $40.4 million, or $0.43 per diluted share for the full yearDURHAM, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading...

Advancing innovation, strengthening partnerships, and powering growth for credit unions nationwide. Irvine, CA, Feb. 26, 2026 (GLOBE NEWSWIRE) — Origence, the leading lending technology solutions provider for credit unions, closed 2025 with $62 billion in total fundings, up 17% from 2024, and signed 89 new or expanded credit union contracts. Together, the network of CUDL credit unions maintained their position as the nation’s largest auto lender as an aggregate for the fifth consecutive year. Growth was supported by advancements in AI-driven automation and strategic partnerships aimed at driving efficiency and enhancing member experiences. Origence’s document processing automation (DPA) improved funding efficiency for credit unions by 50%. In addition, the company strengthened intelligent underwriting through integrations with...

Fourth Quarter Fiscal 2025 Results(All comparisons versus prior year period unless noted.)Revenues of $1.9 billion, down 11%, due to the slower pace of awards and contingency EUCOM scope reductions Net income attributable to KBR of $111 million, up 46%; Operating income of $191 million, up 36% with an Operating income margin of 10.1%; Adjusted EBITDA2 of $238 million, up 5% with an Adjusted EBITDA2 margin of 12.6% Diluted EPS of $0.87, up 53%; Adjusted EPS2 of $0.99, up 10% Bookings and options1 of $2.0 billion with 0.9x book-to-bill1Fiscal 2025 Results(All comparisons versus prior year period unless noted.)Revenues of $7.8 billion, up 1% Net income attributable to KBR of $415 million, up 11%; Operating income of $778 million, up 18% with an Operating income margin of 10.0%; Adjusted EBITDA2 of $968 million, up 12% with an Adjusted...

Strong Finish to 2025; Record Full Year Revenue and Gross Margins COSTA MESA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 RecapNet revenue of $215.8 million, an increase of 9.4% over Q4 2024 Gross margin of 27.7% showed year-over-year growth of 420 bps Net income of $7.4 million increased 10% year-over-year, or $0.48 per diluted share, or 3.4% of revenue Non-GAAP adjusted net income for the quarter of $16.2 million which increased 43% year-over-year, or $1.05 per diluted share Adjusted EBITDA of $37.9 million (increase of 39% year-over-year), or 17.5% of revenue, up 370 bps year-over-year Revenue Remaining Performance Obligations (“RPO”) at a new record of $1.1 billion...

Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organicallyFull year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and 8% on an organic basisFull year 2025 Prevention & Recovery sales grew 4% Y/Y on a reported and organic basisDallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET. Fourth Quarter 2025 Financial Results Enovis’ fourth-quarter net sales of $576 million grew 3% on a reported basis and 2% on an organic basis from the same quarter in 2024. Fourth-quarter...

BOSTON HEIGHTS, Ohio, Feb. 26, 2026 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, reported fourth quarter and full year results for the period ended December 31, 2025, and announced a special cash dividend. Full Year 2025 HighlightsNet revenue increased 8.5% to $1,379 million, compared to the full year of 2024 Gross margin increased 7.0% to $536 million, compared to the full year of 2024 Selling, general and administrative expenses increased 7.7% to $447 million, compared to the full year of 2024 Net and comprehensive income decreased 1.9% to $67 million, compared to the full year of 2024 Adjusted EBITDA increased 8.9% to $145 million, compared to the full year of 2024 Comparable Delivered...